-
Gennaro Gattuso returns to coaching with Lazio after Italy debacle
-
Kenya halts US Ebola facility: health minister tells court
-
Why the heat is wreaking havoc on Europe's trains
-
Zelensky to skip key Ukraine conference in Poland over WWII row
-
Seoul leads rout for tech shares as oil prices dip
-
Europe heatwave closes schools, threatens health
-
India monsoon sweeps north but brings less rain than usual
-
Germany eyes longer working lives in pension reform plan
-
UK and markets await Burnham's economic plans
-
Heineken names new CEO after predecessor's shock departure
-
Banned Vondrousova insists she has 'never doped'
-
Schools plan to close as UK braces for record-breaking heatwave
-
UN chief urges AI firms to 'come clean' over environmental footprint
-
More records set to fall as deadly Europe heatwave drags on
-
Israel's 'deliberate targeting' of children part of ongoing Gaza 'genocide': UN probe
-
England, Ghana eye last 32 as Portugal look for lift-off
-
Sri Lanka troops to battle deadly dengue mosquitoes as cases rise
-
Iran says to oversee Hormuz as Swiss talks conclude
-
Diaspora World Cup champions diversity over division
-
Guns, drones and doves: War reshapes Ukrainian jewellery scene
-
Australia withholds Pacific climate fund reports over risk of diplomatic 'damage'
-
Kenya police violence victims say compensation promise a 'smokescreen'
-
Indian startup head appointed as new WhatsApp boss
-
EU bets on digital euro to cut US tech addiction
-
Antetokounmpo joining Miami Heat in blockbuster: reports
-
Fineanganofo rethinks Newcastle move after All Blacks call-up
-
'Let's be realistic': Haaland cools Norway's World Cup expectations
-
Stocks fluctuate after Wall St sell-off, crude holds losses on peace talks
-
Lightning, downpour, a two-hour delay: bad weather hits the World Cup
-
Ultra-reclusive Turkmenistan slowly opens up to tourists
-
Two-goal Haaland fires Norway into World Cup last 32
-
Marc Bloch, historian and Resistance hero, joins France's Pantheon greats
-
Last one the best one? How Messi keeps doing it at World Cup
-
Ronaldo 'a role model' says Portugal coach after slow World Cup start
-
North Korea's Kim vows to accelerate military buildup
-
Savea 'embraces challlenge' of leading All Blacks towards World Cup
-
Latin America's resurgent right notches another win in Colombia
-
Mbappe scores twice as France beat Iraq at World Cup after two-hour storm delay
-
Trump threatens prison for damage to Washington Reflecting Pool
-
Shortages ease in Bolivia as protest roadblocks dismantled
-
World Cup exploits of Maradona and Messi have Argentina fans in raptures
-
Silver Spruce Resources, Inc. Adds Mine Production Knowledge to the Board
-
GPOPlus+ (OTCQB:GPOX) Releases Retail Investor Memo Highlighting Proven DSD Model, 6x Revenue Growth, and Scalable Path in $50B Underserved Market
-
Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule
-
As Global Demand for Electric Vehicles Accelerates Amid Rising Fuel Costs, Growing Numbers of Investors Worldwide Are Discovering ELEKTROS Inc.'s Vision for Lithium Mining, Critical Minerals, and Patented EV Multi‑Plug Charging Technology
-
Mamatha Chamarthi, Former Stellantis C-Level Software Business Growth Auto Exec and AI Transformation Leader, Featured in Bloomberg and LA Times Coverage on Ferrari EV and the Future of Automotive Identity
-
Humans Hallucinate too. 60% of Public Company Contracts Contain Errors.
-
Revecore Launches ReClaim(TM), an AI-Native Platform Built for the Complexity Modern Hospitals Face
-
Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
-
Amdocs Expands Store Genie to PLDT Home, Bringing Agentic AI to Broadband Customer Service Operations
TailorMed Expands its Solutions Suite to Address Barriers Across the Medication Journey, Building on its Market-Leading Affordability Solution and Growing its National Network
Expanded capabilities help patients and partners navigate access, affordability, and adherence across the healthcare ecosystem
NEW YORK CITY, NY / ACCESS Newswire / April 23, 2026 / TailorMed, the medication success platform removing barriers across the patient journey, today announced a new chapter in its growth, extending its affordability solutions to tackle additional barriers across access and adherence.
While affordability remains a core challenge, patients often encounter multiple barriers that prevent them from starting and staying on therapy, from delays at the point of prescription to lack of ongoing support after treatment begins. TailorMed is building on its leadership in affordability to address these gaps, connecting patients, providers, pharmacies, and life sciences companies through a rapidly growing network that has reached an inflection point in its size, reach, and scale. This approach delivers coordinated support across the medication journey, helping patients start therapy faster, access available financial assistance, and remain adherent over time.
Today, TailorMed's network includes more than 5,000 hospitals and clinics, 3,100 pharmacies, and over 100 embedded pharma program partnerships, with access to thousands of patient support programs, all reaching more than 75 million patients nationwide.
"Affordability is a huge problem and remains at the heart of what we do," said Srulik Dvorsky, CEO of TailorMed. "But for patients, it's rarely the only challenge. We built TailorMed to remove the barriers standing between patients and their care, and we feel privileged to now do that more broadly, breaking barrier after barrier at scale. This marks a new era for TailorMed, taking our mission to a new level."
TailorMed addresses these challenges through a unified platform that delivers the right support at the right time:
TailorMed Core is a care team-facing solution that streamlines and automates the full lifecycle of patient support programs
TailorMed Connect is a self-serve medication journey companion for patients, featuring a copay wallet that makes it easier to access and use financial assistance in real time
TailorMed Complete combines automation with human support in an advanced tech-enabled service
TailorMed Amplify delivers vital life sciences programs digitally across TailorMed's network
TailorMed Alliance expands patient reach and resources through a growing partner ecosystem
Together, these solutions create a coordinated system designed to improve access and affordability while supporting long-term adherence.
TailorMed's network has scaled to reach 335M prescriptions annually. In total, TailorMed has secured $7.4B in patient assistance, reflecting the growing impact of the network and a connected approach.
Dvorsky continued, "The power of the TailorMed network lies in the diversity of its participants and the magnitude of its reach: patients, providers, pharmacies, life sciences companies, and partners across every care setting, disease state, and therapy. The breadth of the network allows TailorMed to purposefully expand its suite of solutions and embedded programs to deliver growing, measurable impact to every network participant."
About TailorMed
TailorMed is the medication success platform removing every barrier across the patient medication journey, from access and affordability through adherence and ongoing care. Through a connected network spanning 945+ hospitals, 4,700+ clinics, 3,100+ pharmacies, 100+ life sciences programs, and 6,000+ support programs, TailorMed has supported over 75 million patients and secured more than $7.4 billion in financial assistance since 2020. TailorMed's platform, including TailorMed Core, TailorMed Connect, TailorMed Complete, TailorMed Amplify, and TailorMed Alliance, connects patients, providers, pharmacies, and life sciences companies through one coordinated network designed to reach every patient at every step of their medication journey. Learn more at tailormed.com.
Contact:
Jennifer Martin
[email protected]
PR Contact:
Glenn Goldberg
Parallel Communications Group
+1 516 776-3282
LinkedIn
𝕏: @Parallel_PR
[email protected]
SOURCE: TailorMed
View the original press release on ACCESS Newswire
S.Gregor--AMWN